Allozymes

Private

SingaporeHealthcare & Life Scienceshttps://www.allozymes.com/

Last Round

Series A

May 14, 2024

Total Funding Raised

$20.26M

Company Overview

Allozymes is a biotechnology company that develops custom enzymes for pharmaceutical, food, and industrial manufacturing using proprietary microfluidics and machine learning technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

enzyme engineeringmicrofluidicsbiocatalysisprotein engineeringhigh-throughput screeningdirected evolutionsynthetic biologybiotech platformenzymatic solutionsmachine learningindustrial biotechcontract researchbioprocess developmentai-driven discoverysynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allozymes Comparables

Compare Allozymes with similar companies based on industry and business-model similarity.

Allozymes comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Allozymes Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	May 14, 2024
Seed	Jul 6, 2021
Accelerator	Dec 4, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Akbar Vahidi

Co-Founder CTO

Founding Team

Peyman Salehian

Co-Founder CEO

Founding Team

Andreas Dr. Reindl

Chief Operating Officer

Executive Team

Allozymes Investors

Notable investors and investment history

Allozymes investors
Investor	Rounds
Transpose Platform Management	Seed
Xora Innovation	Seed, Series A
ID Capital	Series A
Transpose Platform	Series A
Thia Ventures	Series A
Entrepreneurs First	Seed, Series A
SOSV	Seed, Accelerator, Series A

View all Investors

Allozymes Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Allozymes Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allozymes's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore

Employee Range31

Year Founded2019

Last FundingMay 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.